Skip to main content
Equibles

WELLS FARGO & COMPANY/MN

Position in VYGR — Voyager Therapeutics, Inc.

CIK 72971 SAN FRANCISCO, CA
Back to VYGR Full portfolio

Position in VYGR

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$437,647
+$45,002 QoQ
Shares Held
125,042
+22.9% QoQ
Ownership
0.203%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#38
of 135 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in VYGR Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

WELLS FARGO & COMPANY/MN holds $1,575,562,942 across 417 Biotechnology names. VYGR ranks #193 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 749,528 $372,313,040
2 HALO
Halozyme Therapeutics, Inc.
 1,390,428 $108,828,797
3 ALNY
Alnylam Pharmaceuticals, Inc.
 310,047 $93,333,446
4 REGN
Regeneron Pharmaceuticals, Inc.
 140,802 $87,795,677
5 EXEL
Exelixis, Inc.
 717,840 $39,057,673
6 RVMD
Revolution Medicines, Inc.
 178,780 $33,481,916
7 ARGX
Argenx SE
 34,453 $31,964,458
8 INCY
Incyte Corp
 255,064 $28,914,053

All Filings in VYGR

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $437,647 125,042
2026-03-31 $392,645 101,722
2025-12-31 $521,364 132,663
2025-09-30 $488,942 104,699
2025-06-30 $184,331 59,271
2025-03-31 $190,533 56,371
2024-12-31 $378,290 66,718
2024-09-30 $376,259 64,318
2024-06-30 $506,397 64,020
2024-03-31 $537,557 57,740
2023-12-31 $81,994 9,715
2023-09-30 $60,775 7,842
2023-06-30 $171,314 14,962
2023-03-31 $15,927 2,066
2022-12-31 $12,583 2,063
2022-09-30 $13,756 2,324
2022-06-30 $29,046 4,915
2022-03-31 $42,655 5,598
2021-12-31 $91,011 33,584
2021-09-30 $148,549 56,483
2021-06-30 $414,002 100,243
2021-03-31 $369,054 78,356
2020-12-31 $1,006,125 140,717
2020-09-30 $4,626,126 433,564
2020-06-30 $5,856,044 464,029
2020-03-31 $4,189,839 457,906